Increase/Decrease in Cash: The total change in cash for the company over the given period.
OnKure Therapeutics, Inc. (OKUR) had Increase/Decrease in Cash of $133.06M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-15.16M |
|
-- |
|
-- |
|
$15.62M |
|
$-15.62M |
|
$0.46M |
|
$-15.16M |
|
$-15.16M |
|
$-15.16M |
|
$-15.16M |
|
$-15.16M |
|
$-15.16M |
|
$-15.62M |
|
$-15.41M |
|
13.67M |
|
13.67M |
|
$-1.11 |
|
$-1.11 |
|
| Balance Sheet Financials | |
$197.48M |
|
$0.52M |
|
$1.21M |
|
$198.69M |
|
$14.33M |
|
-- |
|
$0.01M |
|
$14.34M |
|
$184.35M |
|
$184.35M |
|
$184.35M |
|
40.40M |
|
| Cash Flow Statement Financials | |
$-12.94M |
|
$-0.01M |
|
$146.00M |
|
$59.05M |
|
$192.11M |
|
|
Increase/Decrease in Cash |
$133.06M |
$2.78M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.78 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.22% |
|
-8.22% |
|
-7.63% |
|
-8.22% |
|
$4.56 |
|
$-0.95 |
|
$-0.95 |
|